On the earnings front, Citigroup�� (C) better than expected report this morning following strong reports from J.P. Morgan (JPM) and Wells Fargo (WFC) on Friday sets us up the stage for a slew of banking sector earnings this week. Q2 earnings growth is resting solely on the banking sector and the group appers on track to come through on the promise.
China�� in-line second quarter GDP growth rate of 7.5% provides further confirmation of a decelerating trend in the world�� second largest economy, but it should ease some of the worst fears that suspected an even weaker showing. The country's new leadership team hasn�� shown any nervousness about the slowdown as they move the economy away from investment-led growth and more geared towards domestic consumption.
Hot Long Term Companies For 2015: Pinnacle Financial Partners Inc.(PNFP)
Pinnacle Financial Partners, Inc. operates as the bank holding company for Pinnacle National Bank that provides commercial banking products and services to individuals, small-to medium-sized businesses, and professional entities in Tennessee. It offers various deposit products, including savings, checking, interest-bearing checking, money market, and certificate of deposit accounts. The company also offers commercial loans comprising equipment loans and working capital loans; commercial and residential real estate loans, and construction and development loans; and loans to individuals for personal, family, investment, and household purposes, including secured and unsecured installment and term loans, residential first mortgage loans, home equity loans, and home equity lines of credit. In addition, it provides various investment products, such as mutual funds, variable annuities, money market instruments, the United States treasury securities, bonds, fixed annuities, stocks , financial planning, asset management accounts, and listed options; fiduciary and investment management services for individual and commercial clients, including personal trust, endowments, foundations, individual retirement accounts, pensions, and custody services; investment advisory services; and insurance products primarily in the property and casualty area. Further, the company offers telephone and Internet banking, debit cards, automated teller machines, remote and direct deposit, and cash management services. As of January 17, 2012, it operated 29 offices in 8 Middle Tennessee counties and 3 offices in Knoxville. The company was founded in 2000 and is headquartered in Nashville, Tennessee.
Advisors' Opinion:- [By Monica Gerson]
Pinnacle Financial Partners (NASDAQ: PNFP) is estimated to post its Q3 earnings at $0.42 per share on revenue of $56.99 million.
Commerce Bancshares (NASDAQ: CBSH) is projected to report its Q3 earnings at $0.72 per share on revenue of $254.92 million.
- [By Brian Pacampara]
What: Shares of Pinnacle Financial (NASDAQ: PNFP ) climbed 10% today after the regional bank's quarterly results topped Wall Street expectations.
Best High Tech Stocks To Watch Right Now: Cooper Companies Inc (COO)
The Cooper Companies, Inc., incorporated on March 4, 1980, is a global medical device company. The Company operates through two business units, CooperVision, Inc. and CooperSurgical, Inc. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women.
CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision's products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness with a collection of spherical, toric and multifocal contact lenses. CooperVision's products are primarily manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and Scottsville, New York. CooperVision distributes products from West Henrietta, New York, Fareham, United Kingdom, Liege, Belgium, and various smaller international distribution facilities. Under the Biofinity brand, CooperVision has launched monthly silicone hydrogel spherical, toric and multifocal lens products. CooperVision has also launched two-week silicone hydrogel spherical and toric lens products under its Avaira brand. During the fiscal year ended October 31, 2013 (fiscal 2013), the Company launched MyDay, its single-use spherical silicone hydrogel lens, in Europe. CooperVision's Proclear line of spherical, toric and multifocal lenses are manufactured with omafilcon, a material that incorporates Phosphorylcholine (PC) Technology that helps enhance tissue-device compatibility.
CooperSurgical offers an array of products used in the care and treatment of women's health. The Company participates in the women's healthcare market through offering quality products, technologies and service to clinicians worldwide. CooperSurgical collaborates with clinicians to identify products and new technologies from dis! posable products to instruments and equipment. The result is a portfolio of products that aid in the delivery of improved clinical outcomes that healthcare professionals use routinely in the diagnosis and treatment of a wide spectrum of women's health issues.
The Company competes with Johnson & Johnson Vision Care, Inc., CIBA Vision, Bausch & Lomb Incorporated, Boston Scientific, Johnson & Johnson's Ethicon Endo-Surgery and Ethicon Women's Health and Urology companies, Gyrus ACMI and Covidien.
Advisors' Opinion:- [By Victor Selva]
The company has a very attractive current ratio of 33.03% which is higher than its comps: Becton Dickinson & Co (BDX), Cardinal Health Inc (CAH), Cooper Companies (COO) and Luxottica Group S.p.A. (LUX).
- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Cooper Cos.(COO) said its revenue jumped more than 6% in its fiscal first quarter, though its profit still fell as result of higher costs and expenses.
- [By Chuck Carnevale]
The following example looking at Cooper Cos. Inc. (COO), and reveals a very cyclical company that provides insight into the PE equals 15 hypotheses that this series of articles has presented. Clearly, price follows earnings even when earnings are dropping, and interestingly, the market tends to apply our standard PE equals 15 even when this happens.
- [By Johanna Bennett]
Copper Cos (COO) shrank 6.5% to $125 after fiscal fourth-quarter earnings and the company�� full-year 2014 financial forecasts fell below expectations. For the period ended Oct. 31, Cooper earned $57.4 million, or $1.15 a share, down from $71.9 million, or $1.46 a share, in the prior-year period. Excluding impacts from a divestiture, adjusted earnings were $1.48, up from $1.47. Revenue gained 3.9% to $411.9 million. Excluding currency impacts, the growth was 7%. �For the new fiscal year, Cooper said it expects per-share earnings of $6.70 to $7 and revenue of $1.675 billion to $1.735 billion Analysts polled by Thomson Reuters were expecting $7 a share in profit and $1.71 billion in revenue.
Best High Tech Stocks To Watch Right Now: Intellipharmaceutics International Inc.(IPCI)
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company?s patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company?s lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a gene ric of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy. Its lead non-generic product under development is Rexista (oxycodone), an abuse- and alcohol-deterrent controlled-release oral oxycodone hydrochloride formulation for the relief of pain. The company also has a under late stage development product, such as Coreg CR (carvedilol phosphate), an extended-release capsule for hypertension and heart conditions. IntelliPharmaCeutics International Inc. was founded in 1998 and is based i n Toronto, Canada.
Advisors' Opinion:- [By Roberto Pedone]
A pharmaceutical player that's starting to trend within range of triggering a big breakout trade is IntelliPharmaCeutics (IPCI), which specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. This stock has been on fire over the last three months, with shares up a whopping 99%.
If you take a look at the chart for IntelliPharmaCeutics, you'll notice that this stock has been uptrending a bit over the last few weeks, with shares moving higher from its low f $3.12 to its recent high of $4.37 a share. During that uptrend, shares of IPCI have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IPCI within range of triggering a big breakout trade above some key overhead resistance levels.
Traders should now look for long-biased trades in IPCI if it manages to break out some near-term overhead resistance levels at $4.37 to $4.62 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.31 million shares. If that breakout triggers soon, then IPCI will set up to re-test or possibly take out its 52-week high at $6.46 a share.
Traders can look to buy IPCI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.36 or at its 50-day moving average of $3.13 a share. One could also buy IPCI off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best High Tech Stocks To Watch Right Now: Officemax Incorporated(OMX)
OfficeMax Incorporated, together with its subsidiaries, distributes business-to-business and retail office products. Its Contract segment markets and sells office supplies and paper, technology products and solutions, office furniture, and print and document services directly to large corporate and government offices, as well as to small and medium-sized offices through field salespeople, outbound telesales, catalogs, Internet, and office products stores. As of December 31, 2011, this segment operated 38 distribution centers in the United States, Puerto Rico, Canada, Australia, and New Zealand; 4 customer service and outbound telesales centers in the United States; and 47 office products stores in Canada, Hawaii, Australia, and New Zealand. The company?s Retail segment markets and sells office supplies and paper, print and document services, technology products and solutions, and office furniture to small and medium-sized businesses and consumers through a network of reta il stores. As of December 31, 2011, this segment operated 978 stores in the United States and Mexico; 3 large distribution centers in the United States; and 1 small distribution center in Mexico. The company, formerly known as Boise Cascade Corporation, was founded in 1913 and is headquartered in Naperville, Illinois.
Advisors' Opinion:- [By Rich Duprey]
For its part, Office Depot says it's a shame it had to waste money going to court to defend against Starboard's action to force an annual meeting. Since they're working on the merger with OfficeMax (NYSE: OMX ) , it was a process that had to play out. That's why they announced last week they were going to have the meeting on Aug. 21.
- [By Rich Duprey]
Office supplies retailer�OfficeMax (NYSE: OMX ) announced yesterday its third-quarter dividend of $0.02 per share, the same rate it's paid for the past four quarters after slashing the payout 87% from $0.15 per share.
- [By Mathew Schwartz]
AlamyA Starbucks coffee shop in downtown Beijing, China. • There are prices to be paid for expanding your economy at a gallop, and China pays plenty of them. Today, anyone looking out across that nation's northern cities can see that winter has arrived there -- or rather, they can't, because the smog is so appallingly bad. In the city of Harbin, for example, visibility dropped to around 11 yards Monday, and small-particle pollution soared to 40 times higher than the international safety standard -- a record, by the way, though one we're sure nobody would want to break. It's a pretty clear case of cause and effect: Harbin's city heating systems were fired up on Sunday, and by Monday, you could barely see your hand in front of your face. • While we're on the subject of the world's rising economic superpower, China has a big complaint with Starbucks (SBUX) -- and it's probably the same one you have: Why does it charge so much for coffee? This may shock those of us in the U.S. who feel we're paying through the nose for our lattes, but Starbucks charges more in China than it does elsewhere -- about a third more than in the United States. • But back in America, the biggest news involving your money today is a no-brainer: the continuing glitches in the Obamacare websites. The administration has called out the computer cavalry, expanding the team that's trying to get the system working properly. And President Obama plans to speak publicly about the problems Monday. But in the meantime, the website is producing far more complaints than anything else. • We all know that taking out a student loan requires filling out a raft of complicated paperwork, but paying it back, at least, ought to be simple. Unfortunately, it's not, the advocates over at the Consumer Financial Protection Bureau inform us in a new report. Some loan servicers -- the companies lenders hire to collect payments on private student loans -- make a concerted effort to maximize fee
- [By Rich Duprey]
As the merger between office products suppliers OfficeMax (NYSE: OMX ) and Office Depot (NYSE: ODP ) wends its way through the regulatory process, they've hired�global talent management consultancy Korn/Ferry International (NYSE: KFY ) to begin the process of finding a CEO to lead the combined companies once the deal is completed.
Best High Tech Stocks To Watch Right Now: Omeros Corporation(OMER)
Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The company?s lead PharmacoSurgery product candidates include OMS103HP, a Phase 3 clinical program evaluated for OMS103HP?s safety and ability to improve postoperative joint function and reduce pain following arthroscopic partial meniscectomy surgery, and arthroscopic anterior cruciate ligament; OMS302, a Phase 2b clinical trial completed product candidate for use during ophthalmological procedures, including cataract and other lens replacement surgery; and OMS201, a Phase 1/Phase 2 clinical trial completed program for use durin g urological surgery. It also engages in developing proprietary compositions that comprise peroxisome proliferator-activated receptor gamma agonists for the treatment and prevention of addiction to substances of abuse. The company?s pipeline of preclinical product development programs includes Plasmin for Surgical and traumatic bleeding; PDE7 for addictions and compulsive disorders, and movement disorders; MASP-2 for macular degeneration, ischemia-reperfusion injury, transplant surgery, and radiation injury; and PDE10 for Schizophrenia. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the move: Boise Inc. (NYSE: BZ) is up 26% at $12.55 following the company�� acquisition by Packaging Corporation of America Inc. (NYSE: PKG) for $12.55 a share ($1.28 billion). Omeros Corp. (NASDAQ: OMER) is up 68.2% at $8.56 following an analyst upgrade. Northern Dynasty Minerals Ltd. (NYSEArca: NAK) is down 33.3% at $1.48 following an announcement from Anglo American plc that it was withdrawing from a massive copper mining project in Alaska.
- [By John Udovich]
The biotech sector has been hot this year with�small cap biotech stocks�Fate Therapeutics Inc (NASDAQ: FATE),�Omeros Corporation(NASDAQ: OMER) and TNI BioTech (OTCMKTS: TNIB) being among those biotech stocks in the news this week. However, there has also been talk�and perhaps�some signs of a bubble in biotech that investors and traders alike need to consider. With that in mind, here is a recap of the latest news for biotech or small cap biotech stocks:
- [By John Udovich]
Small cap orphan drug stocks Zalicus Inc (NASDAQ: ZLCS), Omeros Corporation (NASDAQ: OMER) and Viropharma Inc (NASDAQ: VPHM) have been active lately thanks to good news about their orphan drug treatments. In case you aren�� familiar with the term, orphan drug designation by the FDA is granted for drugs targeting conditions affecting 200,000 or fewer US patients annually that are expected to provide significant therapeutic advantage over existing treatments. The designation will also qualify companies for benefits across all stages of drug development, such as�accelerated approval processes, seven years of market exclusivity�after marketing approval, tax credits on�any US�clinical trials, grants and waiver of certain administrative fees.
Best High Tech Stocks To Watch Right Now: Textron Inc.(TXT)
Textron Inc. operates in the aircraft, defense, automobile, industrial, and finance businesses worldwide. It operates in five segments: Cessna, Bell, Textron Systems, Industrial, and Finance. The Cessna segment manufactures business jets, single engine turboprops, and single engine piston aircraft, as well as provides aftermarket services. The Bell segment manufactures and supplies military and commercial helicopters, tiltrotor aircraft, and related spare parts and services. The Textron Systems segment produces armored security vehicles, marine craft, precision weapons, airborne and ground-based surveillance systems and services, the unmanned aircraft system, training and simulation systems and countersniper devices, and intelligence and situational awareness software. The Industrial segment offers blow-molded plastic fuel systems, windshield and headlamp washer systems, engine camshafts, plastic bottles, and containers; powered equipment, electrical test and measurement i nstruments, hand and hydraulic powered tools, and electrical and fiber optic assemblies principally used in the electrical construction and maintenance, plumbing, wiring, telecommunications, and data communications industries; and golf cars, professional turf-maintenance equipment, and off-road, multipurpose utility, and specialized turf-care vehicles that are marketed to golf courses, resort communities, municipalities, sporting venues, and commercial and industrial users. The Finance segment provides finance for aircraft, helicopters, and golf and turf-care equipment. The company sells its products through a network of sales representatives, distributors, and authorized independent sales representatives, as well as directly to end users, home improvement retailers, and original equipment manufacturers. Textron Inc. was founded in 1923 and is headquartered in Providence, the Rhode Island.
Advisors' Opinion:- [By Monica Gerson]
Textron (NYSE: TXT) is estimated to report its Q3 earnings at $0.47 per share on revenue of $2.97 billion.
The Interpublic Group of Companies (NYSE: IPG) is projected to report its Q3 earnings at $0.18 per share on revenue of $1.71 billion.
No comments:
Post a Comment